Drug information for SYNAREL

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SPRAY, METERED; NASAL EQ 0.2MG BASE/SPRAY Prescription  (Reference Drug) NAFARELIN ACETATE Nafarelin GD SEARLE LLC 19886
2012-01-17 Letter

2012-01-12 Label

2011-01-11 Label

2011-01-11 Label

2011-01-07 Letter

2011-01-07 Letter

2006-04-13 Label

2006-04-13 Letter

1999-07-21 Review

1998-12-24 Letter

Drug Adverse Effects information for SYNAREL

Role code Indications Reaction # Reports
PS ENDOMETRIOSIS BONE LOSS 1
PS ENDOMETRIOSIS MULTIPLE FRACTURES 1
PS ENDOMETRIOSIS OSTEOPOROSIS 1
SS PRODUCT USED FOR UNKNOWN INDICATION MALAISE 3
Ads by Google